Table 3.
Normal‡ | Doxorubicin treated | |
---|---|---|
CO (L/min) | 8.1 ± 1.2 | 5.8 ± 2.4* |
MAP (mm Hg) | 90 ± 10 | 70 ± 17* |
LAP (mm Hg) | 14 ± 6 | 15 ± 9 |
LVPSP (mm Hg) | 103 ± 9 | 88 ± 22 |
LVEDP (mm Hg) | 16 ± 6 | 15 ± 12 |
peak +dP/dt (mm Hg/s) | 1252 ± 407 | 767 ± 222* |
peak −dP/dt (mm Hg/s) | −2528 ± 866 | −1135 ± 610* |
LVEW (mm Hg·ml) | 8758 ± 2441 | 6001 ± 2751 |
CAF (mL/min) | 207 ± 138 | 77 ± 16 |
CO, cardiac output; MAP, mean arterial pressure; LAP, left atrial pressure; LV, left ventricular; PSP, peak systolic pressure; EDP, end diastolic pressure; EW, external work; CAF, coronary artery flow.
‡normal calves from [18]. *P < 0.05 versus normal.